Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Preclinical evidence points to utility of FR-167653 in organ transplantation

Nov. 24, 2000

Xanthine-based inhibitors of IL-12 signaling patented by Cell Therapeutics

Nov. 20, 2000

E.C. approves Roche's CellCept for prevention of liver transplant rejection

Nov. 20, 2000

Licensing opportunity from NIH: chimeric viruses as vaccine candidates

Nov. 20, 2000

CytRx and Merck enter TranzFect agreement

Nov. 16, 2000

Licensing opportunity from NIH: subunit vaccine for viral diseases

Nov. 16, 2000

FK-3311 reduces ischemia/reperfusion injury to the lung in rat model

Nov. 15, 2000

Galenica and U.S. Navy to evaluate malaria vaccine adjuvant

Nov. 15, 2000

Encouraging preclinical data reported for BioSante's CAP vaccine adjuvant

Nov. 15, 2000

Novel immunomodulators claimed by Abbott in patent literature

Nov. 8, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...